跳至主要内容
临床试验/jRCT1031230368
jRCT1031230368招募中不适用

Effect of tirzepatide on oxidative stress and glucose variability in patients with type 2 diabetes mellitus

Showa University Hospital0 个研究点目标入组 66 人开始时间: 2024年3月5日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
66
主要终点
d-ROMs change from baseline

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
20age old over 至 No limit(—)
性别
All

入选标准

  • a diagnosis of type 2 diabetes mellitus
  • HbA1c 7.0% or more
  • Patients who were treated with regular doses of weekly GLP-1 receptor agonists at least for 12 weeks
  • BMI >= 23
  • written informed consent
  • 20 years and over

排除标准

  • the use of steroids or anti-inflammatory drugs,
  • diabetic ketosis and coma within 3 months before the study,
  • severe infection, severe trauma, pre-and post-operation,
  • an estimated glomerular filtration rate are within 30mL/min/1.73m2,
  • malignancy,
  • pregnancy
  • Patients who are judged as inappropriate for inclusion by phsicians
  • Patients using implantable medical devices such as cardiac pacemakers

结局指标

主要结局

d-ROMs change from baseline

时间窗: after completing 24 weeks of treatment intervention

The change in d-ROMs levels from baseline measurement

次要结局

未报告次要终点

研究者

相似试验